BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Furazolidone

A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)

300+ PubMed studies analyzed · 32 RCTs · Evidence Score: 43.5

Research Domains

Furazolidone has been studied across 12 research domains including 🫁 Liver & Detox, 🦠 Gut & Microbiome, 🫘 Kidney, 🧠 Focus & Attention, ⚡ Energy & Fatigue. The primary research focus is 🫁 Liver & Detox with 8% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Furazolidone, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Nitrofurantoin
12 shared targets
Nitrofurazone
11 shared targets
Methandrostenolone
7 shared targets
Polidocanol
10 shared targets
Methylnitronitrosoguanidine
6 shared targets
Canrenone
7 shared targets
Dydrogesterone
7 shared targets
Itraconazole
7 shared targets
propyl
6 shared targets
Carmustine
5 shared targets
Loading evidence profile...

This evidence profile for Furazolidone is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.